We have examined the promoters of five other ZNF202 target genes [27],[34],[35] (apoA4, apoE, lecithin cholesterol acyltransferase, lipoprotein lipase, and phospholipid transfer protein) and did not find deletions or other aberrations in their ZNF202 cis-element in colon and prostate cancer cells (unpublished data). This evidence concerns the gene LCAT and prostate cancer.